宫内利多卡因灌注在HyFoSy中的镇痛效果:双盲随机对照试验
以色列Shamir医学中心2020年6–9月纳入80例行HyFoSy女性的双盲随机对照试验显示,宫内灌注2%利多卡因组在泡沫灌注阶段的VAS疼痛评分低于生理盐水组(3.0±1.3 vs 6.3±1.5,p=.001),重度疼痛发生率也更低(2.5% vs 45.0%,p=.001)。
要点
- HyFoSy前宫内灌注2%利多卡因可显著降低操作相关疼痛。
- 利多卡因组重度疼痛发生率为2.5%,生理盐水组为45.0%。
- 该方法无副作用、易操作且费用较低,可能改善依从性。
核心结论
- HyFoSy前以利多卡因灌注宫腔可显著减轻该操作引起的疼痛,且无副作用。
研究设计与样本
- 双盲随机对照试验,在以色列Shamir医学中心妇产科于2020年6月至2020年9月开展。
- 共纳入80例行HyFoSy的女性,按预设随机码随机分为利多卡因组40例和生理盐水(安慰剂)组40例。
- 操作前分别行宫内灌注2%利多卡因或单纯生理盐水。
主要发现
- 两组患者特征和产科数据相似。
- 泡沫宫内灌注阶段VAS疼痛评分利多卡因组低于生理盐水组(3.0±1.3 vs 6.3±1.5,p=.001)。
- 重度疼痛发生率利多卡因组低于生理盐水组(2.5% vs 45.0%,p=.001)。
关键数值与推荐
- 主要结局为操作后由女性报告的宫内泡沫灌注阶段VAS疼痛评分。
- VAS为10 cm线段,0=无痛,10=极重度疼痛;按评分分为轻度(1–3)、中度(4–6)、重度(7–10)。
临床怎么用
- HyFoSy前可考虑宫内灌注2%利多卡因以减轻操作疼痛。
- 该方法操作简便、费用较低且无副作用,可能有助于提高HyFoSy的依从性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To evaluate the efficacy of flushing the uterine cavity with lidocaine before hysterosalpingo-foam sonography (HyFoSy) to reduce procedure-related pain. DESIGN: A double-blind randomized controlled trial was conducted at the Department of Obstetrics and Gynecology, Shamir Medical Center, Israel between June 2020 and September 2020 involving 80 women undergoing a HyFoSy procedure. SETTING: University-affiliated medical center. PATIENTS: A total of 40 women were assigned randomly to the lidocaine group and 40 to the saline (placebo) group using a predetermined randomization code. Intrauterine instillation before the procedure consisting of either lidocaine 2% or normal saline alone was conducted, respectively. INTERVENTIONS: The primary outcome measure was the visual analog scale (VAS) pain score during the phase of intrauterine foam instillation reported by the women after the procedure. The VAS consisted of a 10-cm line ranging from 0 to 10 (anchored by 0 = no pain and 10 = very severe pain). On the basis of the VAS scores, the pain level ratings were classified as mild (rated 1-3), moderate (4-6), or severe (7-10). MEASUREMENTS AND MAIN RESULTS: The patient characteristics and obstetric data were found to be similar in both groups. Comparison of the VAS pain scores experienced during the procedure showed that women in the lidocaine flushing group rated the procedure less painful than the women in the saline group (3.0 ± 1.3 vs 6.3 ± 1.5, respectively; p = .001). The incidence of severe pain was significantly lower in the lidocaine group than the saline group (2.5% and 45.0%, respectively, p = .001). CONCLUSION: Lidocaine flushing of the uterine cavity before HyFoSy significantly decreased the pain known to be caused by this procedure and had the advantage of no side effects. It is easily applied, relatively inexpensive, and may affect compliance with this procedure.
引用
- Melcer Y, Nimrodi M, Levinsohn-Tavor O, et al. Analgesic Efficacy of Intrauterine Lidocaine Flushing in Hysterosalpingo-foam Sonography: A Double-blind Randomized Controlled Trial. J Minim Invasive Gynecol. 2020. PMID: 33249268. doi:10.1016/j.jmig.2020.11.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。